Evidence map›Paper›PMID 39330993›Full record

ArticleAging2024

Frailty and pre-frailty associated with long-term diminished physical performance and quality of life in breast cancer and hematopoietic cell transplant survivors.

Najla El Jurdi, Hok Sreng Te, Qing Cao, Char Napurski, Shuo Wang, Andre Robinson, Mukta Arora, Heba ElHusseini, Fiona He, Laura J Niedernhofer and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Najla El JurdiBlood and Marrow Transplant Program, Departments of Medicine and Pediatrics, University of Minnesota, Minneapolis, MN 55454, USA.
Hok Sreng TeDivision of Hematology, Oncology, And Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55454, USA.
Qing CaoMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55454, USA.
Char NapurskiDivision of Hematology, Oncology, And Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55454, USA.
Shuo WangDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55454, USA.
Andre RobinsonDivision of Hematology, Oncology, And Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55454, USA.
Mukta AroraAmgen, Thousand Oaks, CA 91320, USA.
Heba ElHusseiniDivision of Hematology, Oncology, And Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55454, USA.
Fiona HeDivision of Hematology, Oncology, And Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55454, USA.
Laura J NiedernhoferInstitute on the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55454, USA.
Bharat ThyagarajanDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55454, USA.
Anna PrizmentDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55454, USA.
Shernan HoltanDivision of Hematology, Oncology, And Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55454, USA.
Anne Hudson BlaesDivision of Hematology, Oncology, And Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55454, USA.
Matthew J YousefzadehInstitute on the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55454, USA.

Funding

Proteomic aging in adults before and after cancer diagnosisR01CA267977 · NCI · UNIVERSITY OF MINNESOTA · PI PRIZMENT, ANNA · 2022 to 2024
$1.0M
NCI NIH HHS R01 CA267977
6 · The paper itself

Abstract

Physical frailty as a sign of accelerated aging is not well characterized in breast cancer (BC) and hematopoietic cell transplant (HCT) survivors and its correlation with outcomes and quality of life (QOL) is not defined. We conducted a prospective study to determine the prevalence of frailty in adult BC and HCT survivors, examine its impact on QOL, and determine its association with

Indexed as

Breast NeoplasmsCancer SurvivorsFrailtyHematopoietic Stem Cell TransplantationQuality of LifeAdultAgedAged, 80 and overCyclin-Dependent Kinase Inhibitor p16FemaleHumansMaleMiddle AgedPhysical Functional PerformanceProspective StudiesYoung AdultCyclin-Dependent Kinase Inhibitor p16agingbreast cancercellular senescencefrailtyhematopoietic cell transplantation

Identifiers

PMID39330993
PMCPMC11466481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.